
Adarx Pharmaceuticals fell 26.8% from $19.35 to $14.16, behind the S&P 500's −10.6%. Its worst day was Nov 5 (−11.2%), and its low came Nov 18 at $12.82.
Sep 25, 2026 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Adarx Pharmaceuticals closed at its highest level of the year, 6.6% above where the year started.
+2.7% · S&P 500 −0.2%
EPS of $-1.74 missed the $-0.37 estimate on $2.2M revenue (est. $3.4M).
Story events cover the past 12 months · Times ET
−4.8% · S&P 500 −0.4%
Where it ended: a close of $14.16 on Nov 19, 2026. Up next: Q4 2026 earnings on Feb 28, 2027 (EPS est. $-0.39, revenue est. $2.3M).
Nothing in the past 12 months.
All ADRX dividend historyReplay the year: the line draws itself and stops at each of the 2 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ADRX and SPY from Benzinga historical bars. Not investment advice.